Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.02% | 62.89% | -24,415.30% | 101.25% | 1.85% |
| Total Depreciation and Amortization | 22.62% | -65.49% | 218.59% | 21.27% | 60.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.25% | -93.91% | 420.55% | -465.34% | -2.45% |
| Change in Net Operating Assets | 93.17% | -200.31% | -507.13% | 104.20% | -122.69% |
| Cash from Operations | 40.15% | -44.98% | -71.27% | 66.53% | -40.65% |
| Capital Expenditure | -370.00% | 93.61% | -19,450.00% | 98.76% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -227.00% | -0.39% | -5.46% | 724.38% | -73.94% |
| Cash from Investing | -227.55% | 0.97% | -6.82% | 764.29% | -75.15% |
| Total Debt Issued | -- | -- | -100.00% | 75.00% | -- |
| Total Debt Repaid | -- | -- | 100.00% | -75.00% | -- |
| Issuance of Common Stock | 2,499,800.00% | -33.33% | -- | -100.00% | -- |
| Repurchase of Common Stock | -830.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 614,950.00% | -366.67% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -182.59% | 6.91% | 42.42% | -89.97% | 1,202.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -271.71% | -29.14% | -28.86% | 263.39% | -12,774.65% |